TotalMarketCap

Scholar Rock

SRRKNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$5.556 B

$45.63 -1.01%

Close of 6 Nov 2026

As of 6 Nov 2026, Scholar Rock (SRRK) has a market capitalization of $5.56B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$378.0M

Loss-making

Shares outstanding

121,785,282

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #20CG OncologyCGON$5.74B
  2. #21Kodiak SciencesKOD$5.73B
  3. #22Scholar RockSRRK$5.56B
  4. #23CRISPR TherapeuticsCRSP$4.71B
  5. #24Adaptive BiotechnologiesADPT$4.35B

What if Scholar Rock were worth as much as…

Open the what-if tool →

Gold $28.2T

$231,857.85

Per share 5,082× higher

Bitcoin $1.53T

$12,545.42

Per share 275× higher

Apple $5.02T

$41,185.46

Per share 903× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Scholar Rock are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.